Skip to main content
Erschienen in: Journal of Cutaneous Medicine and Surgery 2/2004

01.04.2004 | Basic Clinical Science

Multiple Large-Surface Photodynamic Therapy Sessions with Topical or Systemic Aminolevulinic Acid and Blue Light in UV-Exposed Hairless Mice

verfasst von: Younan Liu, Gilles Viau, Robert Bissonnette

Erschienen in: Journal of Cutaneous Medicine and Surgery | Ausgabe 2/2004

Einloggen, um Zugang zu erhalten

Abstract

Background

The use of photodynamic therapy (PDT) with topical aminolevulinic acid (ALA) on large skin surfaces has recently been reported for patients with multiple actinic keratoses.

Objective

The current study compared the ability of topical and systemic ALA–PDT as well as topical ALA–PDT with blue light to delay the appearance of UV-induced skin cancer using the hairless mouse as a model.

Methods

Groups of hairless mice were exposed daily to UV radiation and weekly to ALA–PDT. Tumor-free survival was compared for mice exposed to UV and treated weekly with ALA–PDT and mice exposed only to UV radiation.

Results

Weekly topical or systemic ALA–PDT was able to delay the induction of skin tumors. A significant difference in tumor-free survival was also observed for both actinic keratoses and invasive squamous cell carcinoma in mice treated weekly with topical ALA–PDT performed with blue light. This was observed even when weekly ALA–PDT was started after 8 weeks of UV exposure.

Conclusion

Large-surface topical ALA–PDT with blue light can delay the appearance of UV-induced actinic keratoses and squamous cell carcinoma in hairless mice.
Literatur
1.
Zurück zum Zitat Wang, I, Bendsoe, N, Klinteberg, CA, et al. 2001Photodynamic therapy vs. cryosurgery of basal cell carcinomas: results of a phase III clinical trialBr J Dermatol144832840CrossRefPubMed Wang, I, Bendsoe, N, Klinteberg, CA,  et al. 2001Photodynamic therapy vs. cryosurgery of basal cell carcinomas: results of a phase III clinical trialBr J Dermatol144832840CrossRefPubMed
2.
Zurück zum Zitat Morton, CA, Whitehurst, C, McColl, JH, et al. 2001Photodynamic therapy for large or multiple patches of Bowen disease and basal cell carcinomaArch Dermatol137319324PubMed Morton, CA, Whitehurst, C, McColl, JH,  et al. 2001Photodynamic therapy for large or multiple patches of Bowen disease and basal cell carcinomaArch Dermatol137319324PubMed
3.
Zurück zum Zitat Hongcharu, W, Taylor, CR, Chang, Y, et al. 2000Topical ALA-photodynamic therapy for the treatment of acne vulgarisJ Invest Dermatol115183192CrossRefPubMed Hongcharu, W, Taylor, CR, Chang, Y,  et al. 2000Topical ALA-photodynamic therapy for the treatment of acne vulgarisJ Invest Dermatol115183192CrossRefPubMed
4.
Zurück zum Zitat Stender, IM, Na, R, Fogh, H, et al. 2000Photodynamic therapy with 5-aminolaevulinic acid or placebo for recalcitrant foot and hand warts: randomised double-blind trialLancet355963966CrossRefPubMed Stender, IM, Na, R, Fogh, H,  et al. 2000Photodynamic therapy with 5-aminolaevulinic acid or placebo for recalcitrant foot and hand warts: randomised double-blind trialLancet355963966CrossRefPubMed
5.
Zurück zum Zitat Shieh, S, Dee, AS, Cheney, RT, et al. 2002Photodynamic therapy for the treatment of extramammary Paget’s diseaseBr J Dermatol14610001005CrossRefPubMed Shieh, S, Dee, AS, Cheney, RT,  et al. 2002Photodynamic therapy for the treatment of extramammary Paget’s diseaseBr J Dermatol14610001005CrossRefPubMed
6.
Zurück zum Zitat Gold MH. A Single-Center, Open-Label Investigatory Study of Photodynamic Therapy in the Treatment of Moderate to Severe Acne Vulgaris with Aminolevulinic Acid Topical Solution 20% and Visible Blue Light. 2003. Poster presented at the 61st Annual Meeting of the American Academy of Dermatology, San Francisco, 2003 Gold MH. A Single-Center, Open-Label Investigatory Study of Photodynamic Therapy in the Treatment of Moderate to Severe Acne Vulgaris with Aminolevulinic Acid Topical Solution 20% and Visible Blue Light. 2003. Poster presented at the 61st Annual Meeting of the American Academy of Dermatology, San Francisco, 2003
7.
Zurück zum Zitat Gold MH. A Single-Center, Open-Label Investigatory Study of Photodynamic Therapy in the Treatment of Photoaging with Aminolevulinic Acid Topical Solution 20% and Intense Pulsed Light. 2003. Poster presented at the 61st Annual Meeting of the American Academy of Dermatology, San Francisco, 2003 Gold MH. A Single-Center, Open-Label Investigatory Study of Photodynamic Therapy in the Treatment of Photoaging with Aminolevulinic Acid Topical Solution 20% and Intense Pulsed Light. 2003. Poster presented at the 61st Annual Meeting of the American Academy of Dermatology, San Francisco, 2003
8.
Zurück zum Zitat Weinstein GD, Taylor JR, Glazer SD, et al. A Dose-Ranging Study of Photodynamic Therapy With Topical 5-Aminolevulinic Acid for Treatment of Actinic Keratoses. 2003. Poster presented at the 61st Annual Meeting of the American Academy of Dermatology, San Francisco, 2003 Weinstein GD, Taylor JR, Glazer SD, et al. A Dose-Ranging Study of Photodynamic Therapy With Topical 5-Aminolevulinic Acid for Treatment of Actinic Keratoses. 2003. Poster presented at the 61st Annual Meeting of the American Academy of Dermatology, San Francisco, 2003
9.
Zurück zum Zitat Stender, IM, Bech–Thomsen, N, Poulsen, T, et al. 1997Photodynamic therapy with topical delta-aminolevulinic acid delays UV photocarcinogenesis in hairless micePhotochem Photobiol66493496PubMed Stender, IM, Bech–Thomsen, N, Poulsen, T,  et al. 1997Photodynamic therapy with topical delta-aminolevulinic acid delays UV photocarcinogenesis in hairless micePhotochem Photobiol66493496PubMed
10.
Zurück zum Zitat Sharfaei, S, Viau, G, Lui, H, et al. 2001Systemic photodynamic therapy with aminolevulinic acid delays the appearance of ultraviolet-induced skin tumours in miceBr J Dermatol14412071214CrossRefPubMed Sharfaei, S, Viau, G, Lui, H,  et al. 2001Systemic photodynamic therapy with aminolevulinic acid delays the appearance of ultraviolet-induced skin tumours in miceBr J Dermatol14412071214CrossRefPubMed
11.
Zurück zum Zitat Sharfaei, S, Juzenas, P, Moan, J, et al. 2002Weekly topical application of methyl aminolevulinate followed by light exposure delays the appearance of UV-induced skin tumours in miceArch Dermatol Res294237242PubMed Sharfaei, S, Juzenas, P, Moan, J,  et al. 2002Weekly topical application of methyl aminolevulinate followed by light exposure delays the appearance of UV-induced skin tumours in miceArch Dermatol Res294237242PubMed
12.
Zurück zum Zitat Gruijl, FR, Leun, JC 1991Development of skin tumours in hairless mice after discontinuation of ultraviolet irradiationCancer Res51979984PubMed Gruijl, FR, Leun, JC 1991Development of skin tumours in hairless mice after discontinuation of ultraviolet irradiationCancer Res51979984PubMed
13.
Zurück zum Zitat Hurks, HM, Out–Luiting, C, Vermeer, BJ, et al. 1997 In situ action spectra suggest that DNA damage is involved in ultraviolet radiation-induced immunosuppression in humansPhotochem Photobiol667681PubMed Hurks, HM, Out–Luiting, C, Vermeer, BJ,  et al. 1997 In situ action spectra suggest that DNA damage is involved in ultraviolet radiation-induced immunosuppression in humansPhotochem Photobiol667681PubMed
14.
Zurück zum Zitat Roberts, LK, Beasley, DG, Learn, DB, et al. 1996Ultraviolet spectral energy differences affect the ability of sunscreen lotions to prevent ultraviolet-radiation-induced immunosuppressionPhotochem Photobiol63874884PubMed Roberts, LK, Beasley, DG, Learn, DB,  et al. 1996Ultraviolet spectral energy differences affect the ability of sunscreen lotions to prevent ultraviolet-radiation-induced immunosuppressionPhotochem Photobiol63874884PubMed
15.
Zurück zum Zitat Learn, DB, Beasley, DG, Giddens, LD, et al. 1995Minimum doses of ultraviolet radiation required to induce murine skin edema and immunosuppression are different and depend on the ultraviolet emission spectrum of the sourcePhotochem Photobiol6210661075PubMed Learn, DB, Beasley, DG, Giddens, LD,  et al. 1995Minimum doses of ultraviolet radiation required to induce murine skin edema and immunosuppression are different and depend on the ultraviolet emission spectrum of the sourcePhotochem Photobiol6210661075PubMed
Metadaten
Titel
Multiple Large-Surface Photodynamic Therapy Sessions with Topical or Systemic Aminolevulinic Acid and Blue Light in UV-Exposed Hairless Mice
verfasst von
Younan Liu
Gilles Viau
Robert Bissonnette
Publikationsdatum
01.04.2004
Erschienen in
Journal of Cutaneous Medicine and Surgery / Ausgabe 2/2004
Print ISSN: 1203-4754
Elektronische ISSN: 1615-7109
DOI
https://doi.org/10.1007/s10227-004-0117-5

Weitere Artikel der Ausgabe 2/2004

Journal of Cutaneous Medicine and Surgery 2/2004 Zur Ausgabe

Classics in Dermatology

Scabies by Kenneth Mellanby

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Studienlage spricht für Isotretinoin zur Rosazea-Therapie

23.05.2024 Rosazea Nachrichten

Isotretinoin wird off-label zur Behandlung von Rosazea eingesetzt. Wie solide die Evidenz dafür ist, wurde jetzt in einem systematischen Review überprüft.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Riesenzellarteriitis: 15% der Patienten sind von okkulter Form betroffen

16.05.2024 Riesenzellarteriitis Nachrichten

In einer retrospektiven Untersuchung haben Forschende aus Belgien und den Niederlanden die okkulte Form der Riesenzellarteriitis genauer unter die Lupe genommen. In puncto Therapie und Rezidivraten stellten sie keinen sehr großen Unterschied zu Erkrankten mit kranialen Symptomen fest.

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.